Skip to main content

Table 1 Patient Characteristics

From: Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation

Variable SATB1 low (N = 32) SATB1 high (N = 20) P value
Median (range) No. Median (range) No.
Age, years 50.5 (19–78)   51 (16–79)   0.839
 ≤ 55   19   12
 > 55   13   8
Gender 0.430
 Male   18   9
 Female   14   11
WBC (× 109) 16.82 (0.7–198.34)   11.32 (0.6–283.8)   0.549
RBC (× 1012) 2.4 (1.33–4.49)   2.715 (1.25–4.04)   0.706
HGB (g/L) 72 (49–120)   83.5 (40–129)   0.600
PLT (× 109) 47 (3–97)   56 (8–104)   0.624
Blast (%) 60 (19.7–100)   71.25 (22–94)   0.420
FAB subtype
 M0   1   0  
 M1   2   3  
 M2   9   6  
 M3   6   3  
 M4   5   3  
 M4Eo   1   0  
 M5   6   4  
 Mixed AML   2   1  
 CR rate   57.14%   76.47% 0.189
 Missing valuea   4   3  
  1. WBC, white blood cell; RBC, red blood cell; HGB, hemoglobin; PLT, platelet; CR, complete remission
  2. aFour patients refused the treatment after diagnosed and three patients died during the first cycle of chemotherapy